series-c-plus
Stage
2018
Founded
4
Investors
About
Prilenia develops a platform focused on combating neurological disorders by repurposing existing drugs to accelerate treatment development.
Explore Prilenia's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.